Rafferty Asset Management, LLC Royalty Pharma PLC Transaction History

Rafferty Asset Management, LLC

$27.6 Billion
Q4 2024

A detailed history of Rafferty Asset Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 14,079 shares of RPRX stock, worth $453,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,079

Previous 15,827 11.04%

Holding current value

$453,203

Previous $447,000 19.69%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $42,441 - $49,625	-1,748 Reduced 11.04%	14,079 $359,000
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $21,708 - $24,791	847 Added 5.65%	15,827 $447,000
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $45,219 - $51,487	-1,722 Reduced 10.31%	14,980 $395,000
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $64,942 - $74,095	2,365 Added 16.5%	16,702 $507,000
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $45,526 - $50,755	1,737 Added 13.79%	14,337 $402,000
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $74,604 - $89,150	2,841 Added 29.11%	12,600 $341,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $53,220 - $65,734	1,798 Added 22.59%	9,759 $299,000
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $28,378 - $34,120	866 Added 12.21%	7,961 $286,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $57,501 - $64,650	1,468 Added 26.09%	7,095 $280,000
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $9,132 - $10,224	-229 Reduced 3.91%	5,627 $226,000
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $208,404 - $245,553	-5,553 Reduced 48.67%	5,856 $246,000
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $431,689 - $489,078	-11,524 Reduced 50.25%	11,409 $444,000
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $106,072 - $128,119	3,016 Added 15.14%	22,933 $914,000
Q3 2021 Nov 10, 2021	BUY	$36.14 - $42.24 $314,562 - $367,656	8,704 Added 77.62%	19,917 $720,000
Q2 2021 Aug 10, 2021	BUY	$39.85 - $46.63 $121,941 - $142,687	3,060 Added 37.53%	11,213 $460,000
Q1 2021 May 10, 2021	SELL	$42.34 - $52.82 $137,562 - $171,612	-3,249 Reduced 28.5%	8,153 $356,000
Q4 2020 Feb 10, 2021	BUY	$36.12 - $50.05 $57,033 - $79,028	1,579 Added 16.07%	11,402 $571,000
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $378,774 - $475,040	9,823 New	9,823 $413,000

Others Institutions Holding RPRX

# of Institutions

450

Shares Held

296M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Royalty Pharma PLC Transaction History